EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Aehr Test Systems
AEHR

AEHR Aehr Test Systems

Aehr Test Systems · NASDAQ
Market Closed
94.69
▲ ⁦+0.94%⁩ (+0.88)
Market Cap$3.1B
Beta3.09
52w Low52w High
18.70147.40
Last Week
⁦+18.01%⁩
Last Month
⁦-8.13%⁩
Last 3 Months
⁦+2.56%⁩
Last Year
⁦+289.67%⁩
EL7 Factor Analysis
How we score this
Overall15
Poor — bottom quartile of the marketMomentum TrapF 2/9SafeBetter than 15% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
10
—17.8xBottom tier
▸
Growth
23
-15.2%▼7.1%Bottom tier
▸
Quality
29
-5.2%▼4.5%Bottom tier
▸
Safety
74
—2.6xTop tier
▸
Capital Return
67
—2.12%Top tier
▸
Momentum
85
285.2%▲2.9%Top tier
▸
Sentiment
21
2▼3Bottom tier
Fair Value
Low confidenceCurrent price$95
Analyst target · 1 analysts
$123
⁦+29%⁩
See it clearly undervalued
Range ⁦$110–$175⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$132.50
⁦+39.9%⁩
Current Price $94.69·Median $122.50
Low
$110.00
High
$175.00
Current price
$94.69
Average target
$132.50
Street summary

Consensus target rises with slight short-term decline

The consensus target price rose to 132.5, an increase of 15 or 12.77% over the last 30 days, but declined by 4.17 or 3.05% over the last 7 days, while remaining unchanged over the last day. The current price is 94.69, making the consensus higher than it, but the number of analysts remained at one; therefore, the figures do not reflect broad agreement. The range is between 110 and 175, with a median of 122.5, indicating notable variation in the only available estimate.

As of 2026-09-11
Revisions momentum · 30d
⁦+12.8%⁩
Average rating
★ 4.00
Buy
Analyst coverage
5
Buy conviction
100%
High
Rating activity · 30d
0↑ · 0↓
Target dispersion
69%
Wide
Analyst ratings over time5 analysts rating
5
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.60 → 4.00
Recent analyst moves
  • = Reiterate2026-09-10
    Oppenheimer
    Outperform
  • = Reiterate2026-08-13
    Jefferies
    Buy
  • = Reiterate2026-07-15
    Craig-Hallum
    Buy
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    —
    —
  • Forward P/E
    486.70x
    5.19x41.53x
    Very expensive
  • EV / EBITDA
    —
    —
  • FCF Yield
    -0.2%
    -54.8%10.8%
    Strong
  • Revenue Growth YoY
    -15.2%
    -18.1%66.5%
    Weak
  • EPS Growth YoY
    -77.2%
    -155.3%193.7%
    Below average
  • Gross Margin
    35.3%
    12.9%79.5%
    Near median
  • ROIC
    -5.2%
    -63.6%26.5%
    Above average
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    68.83
    -10.9113.66
    Exceptional
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-14 data

Company Overview

Aehr Test Systems develops semiconductor burn-in and test systems at the wafer level and package level, serving artificial intelligence processors, silicon photonics, and power semiconductors. The company generates revenue from sales of FOX and Sonoma platforms, along with consumable and recurring components such as WaferPak and burn-in boards; contactor revenue reached $5.8 million, or 31% of fiscal Q4 2026 revenue. WaferPak technology enables temperature control for each die, while FOX systems can process up to nine wafers in parallel, supporting their use in high-volume production testing.

Fiscal Q4 2026 revenue was approximately $18.8 million, up 34% from $14.1 million in the comparable period, and gross profit under EDGAR was approximately $8.0 million, equivalent to a gross margin of about 42.6%, while the company recorded net income of $1.4 million. On a non-GAAP basis, gross margin was 45% and net income was $3.6 million, or $0.11 per diluted share. Artificial intelligence processors and silicon photonics accounted for more than 80% of quarterly revenue, compared with 56% in the comparable period.

For fiscal 2026, revenue was $50.0 million, down 15%, gross profit under EDGAR was approximately $17.7 million, net loss was $7.1 million, and loss per share was $0.23. Annual non-GAAP gross margin was 38.5%, compared with 44% in fiscal 2025, while burn-in and screening applications for artificial intelligence processors, central processing units, and network processors contributed approximately 71% of annual revenue, and testing of optical devices and data center infrastructure added approximately 20%. The company ended the year with cash, cash equivalents, and restricted cash of $116.5 million after raising approximately $100 million, primarily through its at-the-market program.

What's Driving the Stock

  • Bookings in fiscal Q4 2026 reached a record $60.7 million, up more than 500% from $11.1 million, and year-end backlog reached $80.6 million, compared with $15.2 million; following $20 million in additional bookings, effective backlog rose to approximately $100.6 million before accounting for limited shipments during the transition period ended June 26, 2026.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • Management expects fiscal 2027 revenue of between $130 million and $150 million, representing annual growth of between 160% and 200%, with non-GAAP pretax profit equal to 18% to 22% of revenue. Most of this range depends on existing customers, and the estimate does not include memory revenue, while some new opportunities could add to the range if they convert into orders.
  • On August 12, 2026, Aehr announced an additional $22 million production order from its lead artificial intelligence processor customer to provide wafer-level test systems for training and inference processors. This follows a $41 million order the company received in April 2026 from a high-performance computing customer for Sonoma systems, and management expects package-level Sonoma revenue to total approximately $50 million within the fiscal 2027 mix.
  • The company completed benchmark testing of its wafer-level burn-in solution at a major supplier of artificial intelligence accelerator processors, central processing units, and network processors, and management said the results exceeded the customer's expectations and were better than package-level test results. The customer requested a move to pilot-production validation at a contract manufacturer in Taiwan for an existing high-volume device and also requested the parallel evaluation of a second device, with this opportunity's contribution remaining very limited or not included in fiscal 2027 guidance.
  • The application base is expanding beyond artificial intelligence; on August 4, 2026, the company received a production order for a fully automated FOX-XP system from a silicon photonics customer, and during its July 14, 2026 call, it also reported receiving approximately $8 million in silicon carbide burn-in and WaferPak orders within one month. Aehr also completed its first burn-in solution for a 300 mm GaN wafer and sold its first FOX system for a silicon MOSFET application, expanding its potential market in power, automotive, and data centers.
  • The company increased its manufacturing capacity by shipping Sonoma systems from an existing contract manufacturer in Southeast Asia with capacity for more than 20 additional systems per month, alongside an expansion in Fremont and an increased support presence in Hsinchu, Taiwan. Management says this infrastructure does not constrain production at the $150 million revenue level, an important factor in fulfilling the backlog and delivering concentrated Sonoma volumes in fiscal Q2 2027.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +The effective backlog of approximately $100.6 million provides tangible coverage for a large portion of the low end of fiscal 2027 revenue guidance of $130 million, while most of the expected range depends on existing customers rather than unproven opportunities.
    • +Aehr has shifted from more than 95% dependence on electric-vehicle silicon carbide two years ago to a mix in which approximately 95% of fiscal 2026 revenue came from other markets, led by artificial intelligence processors at approximately 71% and optical devices at 20%. This diversification reduces the new growth trajectory's dependence on the recovery of a single market.
    • +Fiscal Q4 2026 economics improved markedly, as revenue rose 34% and non-GAAP gross margin reached 45%, compared with 35% in the comparable period, alongside improved manufacturing capacity utilization and product mix. Management targets a non-GAAP pretax profit margin of between 18% and 22% in fiscal 2027.
    • +The company combines system sales with WaferPak components and burn-in boards, and contactors represented 31% of fiscal Q4 2026 revenue. Deploying FOX systems across additional devices and customers could generate subsequent demand for WaferPak designs and consumables, instead of relying exclusively on large system transactions.

    ▼ Selling Case6 pts

    • −Despite the strength of the latest quarter, fiscal 2026 revenue declined 15% to $50.0 million, annual non-GAAP gross margin fell to 38.5% from 44%, and the financial statements under EDGAR recorded a net loss of $7.1 million. Therefore, reaching revenue of between $130 million and $150 million in fiscal 2027 requires a substantial operational reversal compared with the completed year's performance.
    • −Concentration remains high; artificial intelligence and silicon photonics applications accounted for more than 80% of fiscal Q4 2026 revenue, and three customers each represented more than 10% of revenue. Most of fiscal 2027 guidance also depends on existing customers, making the delay of a major program or a change in its delivery schedule disproportionately impactful.
    • −Revenue timing will be volatile, as management expects to deliver most of the Sonoma systems in backlog during fiscal Q2 2027 and sees the possibility that the first half will equal or exceed the second half. This timing concentration increases quarterly results' sensitivity to any delay in system manufacturing, acceptance, or shipment.
    • −Aehr faces supply and execution risks while ramping production; management reported that some power-module suppliers raised prices by 40% to secure components, with some long-lead-time items. Despite increasing manufacturing capacity to more than 20 additional Sonoma systems per month in Southeast Asia, management emphasized that scaling production to targeted levels is a difficult process and not automatic.
    • −The company competes with Semi, which was reestablished in Malaysia as Nexus Test, and is pursuing a patent-infringement lawsuit against it related to wafer-level silicon carbide burn-in systems. Aehr's two Chinese patents were upheld, but the case was still ongoing as of July 14, 2026, and the company expects additional legal expenses in subsequent quarters to protect its intellectual property.
    • −

    Valuation

    The average analyst price target is $136.67, with a wide range of $110 to $175 and a Neutral consensus; the average is approximately 7% below the 52-week high of $147.4, while the highest target exceeds that high. No positive price-to-earnings ratio is available following a fiscal 2026 net loss of $7.1 million, so the valuation depends heavily on executing fiscal 2027 revenue guidance of $130 million to $150 million and achieving a non-GAAP pretax profit margin of between 18% and 22%. The difference between the lowest and highest targets, together with the 52-week range of $18.7 to $147.4, confirms that the market and analysts assign varying outcomes to the likelihood of converting backlog into revenue and profitability.

    HoldAnalyst target: $136.67(+44.3%)

    Figures in the text are as of 2026-09-01; the live price is shown at the top of the page.

    FAQ

    What is driving Aehr Test Systems' growth in fiscal 2027?

    Management expects fiscal 2027 revenue of between $130 million and $150 million, compared with $50.0 million in fiscal 2026, equivalent to growth of between 160% and 200%. This is supported by an effective backlog of approximately $100.6 million after adding $20 million in bookings following year-end. Management expects approximately 70% of the mix to come from artificial intelligence, approximately 15% to 20% from silicon photonics, with the remainder contributed by power semiconductors and other applications. The guidance does not include memory revenue, and the contribution from the new benchmark-testing customer is very limited or not included.

    How significant are the $41 million and $22 million artificial intelligence orders for AEHR stock?

    In April 2026, Aehr received a record $41 million order from a high-performance computing customer for Sonoma systems and their consumables, with the systems scheduled to go to an assembly and test service provider in Taiwan. On August 12, 2026, the company announced an additional $22 million production order from its lead artificial intelligence processor customer for wafer-level test systems. Management indicates that package-level Sonoma revenue could reach approximately $50 million within the fiscal 2027 mix, with a significant portion of shipments concentrated in fiscal Q2 2027. The two transactions demonstrate the company's exposure to both package-level burn-in and wafer-level burn-in within the artificial intelligence processor market.

    Did Aehr's profitability improve in fiscal Q4 2026?

    Fiscal Q4 2026 revenue was approximately $18.8 million, up 34% from $14.1 million in the comparable period. The financial statements under EDGAR recorded gross profit of $8.0 million and net income of $1.4 million, while non-GAAP net income was $3.6 million, or $0.11 per diluted share. Non-GAAP gross margin increased to 45% from 35% due to higher revenue, improved manufacturing utilization, and product mix. However, full-year fiscal 2026 remained weaker, with revenue declining 15% and an EDGAR net loss of $7.1 million.

    How is Aehr expanding beyond the electric-vehicle silicon carbide market?

    Two years ago, more than 95% of Aehr's business was tied to electric-vehicle silicon carbide, while approximately 95% of fiscal 2026 revenue came from other markets. Artificial intelligence processors, central processing units, and network processors represented approximately 71% of annual revenue, and optical devices and data center components added approximately 20%. On August 4, 2026, the company announced an order for a FOX-XP system from a silicon photonics customer, and it also completed its first burn-in solution for a 300 mm GaN wafer and sold its first FOX system for a silicon MOSFET application. However, approximately $8 million in silicon carbide orders during the month preceding the July 14, 2026 call showed that the former market could remain a contributor.

    What are the main risks to monitor in AEHR?

    Three customers each represented more than 10% of fiscal Q4 2026 revenue, while artificial intelligence and silicon photonics applications generated more than 80% of quarterly revenue. Achieving fiscal 2027 guidance requires increasing revenue from $50.0 million to between $130 million and $150 million, with Sonoma shipments concentrated in fiscal Q2 2027. Management also reported a 40% increase in the prices of some power modules and continues to incur expenses related to the Semi and Nexus Test patent lawsuit in China. In addition, insiders recorded net sales of $17.8 million across 17 sales and no purchases during the three months ended with the latest transaction on August 17, 2026, with the caveat that insider sales may be prearranged and are not sufficient on their own to assess the company's outlook.

    No positive price-to-earnings ratio is available because of the $7.1 million fiscal 2026 net loss, while the 52-week range extends from $18.7 to $147.4, reflecting significant volatility in the repricing of growth expectations. The analyst consensus is also Neutral, with targets ranging from $110 to $175, a spread that highlights uncertainty regarding execution of the expected fiscal 2027 surge.